XOMA Royalty Corporation (XOMA)

XOMA Royalty Market Cap

XOMA Royalty has a market cap or net worth of $317.75 million as of January 30, 2026. Its market cap has increased by 0.97% in one year.

• Market Cap: 317.75M
• Enterprise Value: 404.93M
• 1-Year Change: 0.97%
• Ranking: #3472
• Category: Small-Cap
• Stock Price: $25.66

Market Cap Chart

Since December 1, 1998, XOMA Royalty's market cap has increased from $151.40M to $317.75M, an increase of 109.87%. That is a compound annual growth rate of 2.76%.

Market Cap History

Date	Market Cap	% Change
Jan 29, 2026	309.20M	-6.10%
Dec 31, 2025	329.30M	6.36%
Dec 31, 2024	309.60M	45.69%
Dec 29, 2023	212.50M	0.85%
Dec 30, 2022	210.70M	-10.64%
Dec 31, 2021	235.80M	-51.52%
Dec 31, 2020	486.40M	103.60%
Dec 31, 2019	238.90M	125.16%
Dec 31, 2018	106.10M	-63.40%
Dec 29, 2017	289.90M	1,036.86%
Dec 30, 2016	25.50M	-83.86%
Dec 31, 2015	158.00M	-59.01%
Dec 31, 2014	385.50M	-38.46%
Dec 31, 2013	626.40M	220.08%
Dec 31, 2012	195.70M	396.70%
Dec 30, 2011	39.40M	-64.76%
Dec 31, 2010	111.80M	-19.57%
Dec 31, 2009	139.00M	69.31%
Dec 31, 2008	82.10M	-81.63%
Dec 31, 2007	447.00M	100.18%
Dec 29, 2006	223.30M	61.69%
Dec 30, 2005	138.10M	-37.68%
Dec 31, 2004	221.60M	-59.61%
Dec 31, 2003	548.60M	84.40%
Dec 31, 2002	297.50M	-56.92%

View and export this data all the way back to 1998. Sign Up Today.

Related Stocks

Company	Market Cap
Cybin	326.87M
Foghorn Therapeutics	325.71M
Candel Therapeutics	322.80M
Atea Pharmaceuticals	321.10M
Aldeyra Therapeutics	318.26M
Puma Biotechnology	317.97M
Immix Biopharma	313.01M
Larimar Therapeutics	301.71M